Marin A, Mamun AA, Patel H, Akamatsu H, et al. Acquired secondary HER2 mutations enhance HER2/MAPK signaling and promote resistance to HER2 kinase inhibition in breast cancer. Cancer Res 2023 Jul 5:CAN-22-3617. doi: 10.1158/0008-5472.CAN-22-3617.
PMID: 37404061